The Op-Ed: Off-Label Pregnancy Rx Needs More Regs
With all the talk of off-label promotion and commercial free speech, a vexing issue remains – patient safety. A case in point is the use of dexamethasone, which is sometimes given to pregnant women at risk of having a child with congenital adrenal hyperplasia. Prenatal dexamethasone cannot prevent a child being born with CAH, but it may reduce the odds a girl will be born sex atypical from having CAH. A recent paper in AJOG argued against the use because of safety concerns. We asked Alice Dreger, a professor of Clinical Medical Humanities & Bioethics at Northwestern University, to explain… In a legal case ...
Source: Pharmalot - February 27, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Alice Dreger Dexamethasone Medical Ethics Off Label Promotion Source Type: blogs